Viewing Study NCT06375408



Ignite Creation Date: 2024-05-06 @ 8:25 PM
Last Modification Date: 2024-10-26 @ 3:27 PM
Study NCT ID: NCT06375408
Status: RECRUITING
Last Update Posted: 2024-04-19
First Post: 2024-03-26

Brief Title: Transcranial Alternating Current Stimulation Prevents Delirium in Patients With Subarachnoid Hemorrhage
Sponsor: Xuanwu Hospital Beijing
Organization: Xuanwu Hospital Beijing

Study Overview

Official Title: Clinical Study of Transcranial Alternating Current Stimulation in the Prevention of Delirium in Patients With Subarachnoid Hemorrhage
Status: RECRUITING
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: TACS
Brief Summary: The goal of this clinical trial is to learn about using the latest transcranial alternating current stimulation tACS to reduce the incidence of delirium in patients with subarachnoid hemorrhage The main question it aims to answer is

To evaluate the effect of tACS on reducing delirium in patients with subarachnoid hemorrhage

Participants will treated with real tACS or sham tACS Researchers will mainly compare the two groups to see if patients delirium will reduce by using tACS
Detailed Description: Research objectives To reduce the incidence of delirium in patients with subarachnoid hemorrhage by using the latest transcranial alternating current stimulation

Research contents

1 To evaluate the effect of transcranial alternating current stimulation on improving sleep quality in patients with subarachnoid hemorrhage
2 To evaluate the effect of transcranial alternating current stimulation on reducing delirium in patients with subarachnoid hemorrhage

Research hypothesis Transcranial alternating current stimulation can improve sleep quality and reduce the incidence of delirium in patients with subarachnoid hemorrhage

Study design

1 double-blind randomized clinical trial
2 SubjectsPatients with subarachnoid hemorrhage admitted to the neurosurgical intensive care unit during the study period
3 Number of participating centers and names of centers Single research center Xuanwu Hospital Beijing
4 Sample size The total number of plans was 74 and the total number of study centers was 74
5 Grouping of subjectsThe random number table method was used for randomization and the envelope method was used for randomization The random serial number was stored in an airtight envelope a patient was admitted and an envelope was opened
6 Intervention measures ① The control group was treated with sham transcranial electrical stimulation ② The experimental group was treated with real transcranial electrical stimulation
7 Outcome measures ① Efficacy indicators the incidence and duration of delirium The scores of Richard Campell sleep questionnaire Hamilton Anxiety Scale Mini-Mental State Examination numerical rating scale for pain and muscle strength were recorded② Safety indicators the incidence of adverse reactions

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None